{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-014177","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2024-11-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.972165+00:00","generated_at":"2026-05-30T06:34:21.731118+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Owens & Minor Q3 revenue up 5% to $2.7B; GAAP net loss $0.17/shr; adj EPS $0.42; debt cut $198M","bullets":["Consolidated revenue of $2.7B (+5% YoY); GAAP net loss $(13M) or $(0.17)/share.","Adjusted EBITDA $142M (+5% YoY); adjusted EPS $0.42 vs $0.44 prior year.","Total debt reduced by $198M in Q3; management expects sequential growth into Q4.","Patient Direct and Medical Distribution divisions drove top-line growth.","Adjusted net income $33.2M vs $34.1M YoY, reflecting higher interest costs."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-014177","json":"https://secwatch.observer/filing/0001558370-24-014177.json","markdown":"https://secwatch.observer/filing/0001558370-24-014177.md","text":"https://secwatch.observer/filing/0001558370-24-014177.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000155837024014177/0001558370-24-014177-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000155837024014177/tmb-20241104x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T06:34:21.731118+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}